FDA Inspection 1153969 — Blood Bank Of Delmarva, A Division Of New York Blood Center
The FDA completed an inspection of Blood Bank Of Delmarva, A Division Of New York Blood Center on Aug 2, 2021 in Salisbury, MD. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Aug 2, 2021
- Fiscal Year
- 2021
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Salisbury, MD (United States)